Search for a command to run...
Crown Castle Inc.
REIT - Specialty
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Aug 18, 2026 |  Gilbert CisnerosD | Stock | Sell |
| $1,001 - $15,000 |
| $72.97 |
| $73.74 |
| +1.1% |
| +1.7% |
Aug 6, 2026 |  Michael RulliR | Stock | Sell | $1,001 - $15,000 | $74.92 | $75.83 | +1.2% | +1.0% |
Aug 3, 2026 |  Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $76.74 | $75.38 | -1.8% | -2.8% |
Jul 23, 2026 |  Josh GottheimerD | Stock | Sell | $1,001 - $15,000 | $74.57 | $75.51 | +1.3% | -2.5% |
Jul 20, 2026 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $78.18 | $74.65 | -4.5% | -8.1% |
Jul 7, 2026 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $77.22 | $74.92 | -3.0% | -5.8% |
Jun 30, 2026 |  Robert J. WittmanR | Stock | Sell | $1,001 - $15,000 | $74.64 | $75.41 | +1.0% | +1.7% |
May 15, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $85.66 | $91.10 | +6.3% | +6.0% |
May 1, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $88.23 | $90.44 | +2.5% | -2.5% |
Apr 13, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $86.08 | $88.59 | +2.9% | -5.3% |
Mar 24, 2026 | Josh GottheimerD | Stock | Sell | $1,001 - $15,000 | $76.57 | $85.27 | +11.4% | +2.9% |
Mar 23, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $79.24 | $83.80 | +5.8% | -2.8% |
Jan 6, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $85.06 | $76.51 | -10.1% | -8.0% |
Dec 19, 2025 | Gilbert CisnerosD | Stock | Sell | $1,001 - $15,000 | $84.06 | $88.71 | +5.5% | +3.9% |
Dec 5, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $87.15 | $87.61 | +0.5% | +0.6% |
Nov 10, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $89.64 | $88.47 | -1.3% | -2.2% |
Nov 3, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $87.38 | $86.22 | -1.3% | -1.4% |
Sep 29, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $91.48 | $87.80 | -4.0% | -7.6% |
Sep 23, 2025 |  Valerie HoyleD | Stock | Sell | $1,001 - $15,000 | $89.73 | $93.46 | +4.2% | +2.9% |
May 19, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $98.34 | $95.93 | -2.5% | -2.9% |
May 12, 2025 |  Jefferson ShreveR | Stock | Sell | $15,001 - $50,000 | $95.96 | $94.95 | -1.0% | -4.2% |
Apr 21, 2025 |  Bruce WestermanR | Stock | Sell | $1,001 - $15,000 | $97.53 | $96.95 | -0.6% | -14.0% |
Apr 11, 2025 | Jefferson ShreveR | Stock | Buy | $15,001 - $50,000 | $92.32 | $100.27 | +8.6% | +2.9% |
Apr 9, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $91.24 | $100.27 | +9.9% | +7.0% |
Apr 9, 2025 | Josh GottheimerD | Stock | Sell | $1,001 - $15,000 | $91.24 | $100.27 | +9.9% | +7.0% |
Apr 1, 2025 |  Julie JohnsonD | Stock | Sell | $1,001 - $15,000 | $99.90 | $101.51 | +1.6% | +2.1% |
Mar 18, 2025 |  Sheri BiggsR | Stock | Sell | $1,001 - $15,000 | $100.22 | $98.93 | -1.3% | +4.6% |
Mar 3, 2025 | Bruce WestermanR | Stock | Buy | $1,001 - $15,000 | $91.16 | $100.38 | +10.1% | +13.1% |
Feb 25, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $88.76 | $99.20 | +11.8% | +16.0% |
Feb 19, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $84.89 | $102.87 | +21.2% | +28.9% |
Jan 24, 2025 | Gilbert CisnerosD | Stock | Buy | $1,001 - $15,000 | $84.15 | $87.67 | +4.2% | +5.5% |
Jan 22, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $84.10 | $87.67 | +4.3% | +5.3% |
Jan 17, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $86.60 | $83.65 | -3.4% | -5.4% |
Dec 16, 2024 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $91.03 | $82.39 | -9.5% | -7.5% |
Oct 29, 2024 | Valerie HoyleD | Stock | Buy | $1,001 - $15,000 | $99.78 | $99.86 | +0.1% | -2.8% |
Crown Castle (CCI) Faces A Tower Only Test On A Fair Value Gap
Barclays Upgrades Crown Castle (CCI)
Crown Castle Draws an Upgrade With a Lower Price Target
Here Are Thursday’s Top Wall Street Analyst Research Calls: Alphabet, Analog Devices, Crown Castle, ebay, EPR Properties, Etsy, Merck & Co., Shopify, TJX Companies, and More
Barclays Upgrades Crown Castle to Overweight, Lowers Price Target to $84